These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23416621)

  • 1. Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration.
    Wilkaniec A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2013 Apr; 62(5):776-83. PubMed ID: 23416621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide.
    Adamczyk A; Kaźmierczak A; Strosznajder JB
    Neurochem Int; 2006 Sep; 49(4):407-12. PubMed ID: 16546300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases.
    Chavarría C; Souza JM
    Arch Biochem Biophys; 2013 May; 533(1-2):25-32. PubMed ID: 23454347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
    Kazmierczak A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
    Duda JE; Giasson BI; Chen Q; Gur TL; Hurtig HI; Stern MB; Gollomp SM; Ischiropoulos H; Lee VM; Trojanowski JQ
    Am J Pathol; 2000 Nov; 157(5):1439-45. PubMed ID: 11073803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide.
    Black SM; Fineman JR
    Vascul Pharmacol; 2006 Nov; 45(5):308-16. PubMed ID: 17049313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers.
    Kabiraj P; Marin JE; Varela-Ramirez A; Zubia E; Narayan M
    ACS Chem Neurosci; 2014 Dec; 5(12):1209-20. PubMed ID: 25247703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.
    Wilkaniec A; Czapski GA; Adamczyk A
    J Neurochem; 2016 Jan; 136(2):222-33. PubMed ID: 26376455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
    Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
    J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.
    Chinta SJ; Andersen JK
    Free Radic Res; 2011 Jan; 45(1):53-8. PubMed ID: 20815786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.
    Benhar M; Forrester MT; Stamler JS
    ACS Chem Biol; 2006 Jul; 1(6):355-8. PubMed ID: 17163772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
    Gadad BS; Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of extracellular α-synuclein in molecular mechanisms of cell death].
    Kaźmierczak A; Adamczyk A; Benigna-Strosznajder J
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1047-57. PubMed ID: 24184956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.